Association of FDG-PET and Clinical Outcomes in NMDA Receptor Autoimmune Encephalitis
Jeffrey Lambe1, Jonathan Lee2, Scott Johnson2, Akua Abrah3, Tatchaporn Ongphichetmetha1, Jennifer Bullen4, Amy Kunchok1
1Cleveland Clinic Mellen Center for Multiple Sclerosis, 2Cleveland Clinic Department of Radiology, 3Cleveland Clinic Lerner College of Medicine, 4Cleveland Clinic Lerner Research Institute Quantitative Health Sciences
Objective:

To characterize quantitative features of brain 18-fluorodeoxyglucose (FDG)-PET at disease onset in N-methyl-D-aspartate receptor-IgG autoimmune encephalitis (NMDAR-IgG AE) and their association with acute and long-term outcomes.

Background:

There is a paucity of biomarkers predicting clinical outcomes in NMDAR-IgG AE. The role of neuroimaging in NMDAR-IgG AE is incompletely understood.

Design/Methods:

This is an observational cohort study of adult patients with NMDAR-IgG AE (CSF-positive) with early brain FDG-PET (<3 months from onset). Clinical characteristics, including modified Rankin Scale (mRS) and clinical assessment scale in autoimmune encephalitis (CASE), were obtained at baseline (+/-10 days of FDG-PET), and late (>1 year) among a subset of patients. Brain region mean z-scores with a 95% confidence interval (CI) with a lower bound >1 were considered hypermetabolic, and those with an upper bound <-1 were considered hypometabolic. Spearman’s rank correlated FDG-PET measures with clinical outcomes.

Results:

Sixteen patients were included (mean age=29 years [interquartile range [IQR]=23-33]; 13 [81%] female). FDG-PET was performed at a median of 5.1 weeks (IQR=3.6-7.1) post-symptom onset. Of 70 brain regions analyzed, 17- predominantly orbitofrontal/temporal- were hypermetabolic; 12- predominantly occipital- were hypometabolic. Hypometabolic regions exhibited the strongest correlation with cross sectional disability and severity, including lingual gyrus (mRS: ρ=-0.78 [95%CI=-0.92,-0.47]; CASE: ρ=-0.77 [95%CI=-0.92,-0.45]) and primary visual cortex (mRS: ρ=-0.71 [95%CI=-0.89,-0.33]; CASE: ρ=-0.81 [95%CI=-0.93,-0.53]). Among 12 patients with follow-up assessments >1 year later, these hypometabolic regions at baseline FDG-PET continued to show strong correlation with late mRS (lingual gyrus: ρ=-0.73 [95%CI=-0.92,-0.27]; primary visual cortex: ρ=-0.89 [95%CI=-0.97,-0.64]), and modest correlation with late CASE (lingual gyrus: ρ=-0.47 [95%CI=-0.82,0.14]; primary visual cortex: ρ=-0.48 [95%CI=-0.83,0.13]).

Conclusions:

This study observed frequent orbitofrontal/temporal hypermetabolism and occipital hypometabolism on baseline FDG-PET, characteristic of NMDAR-IgG AE. Specifically, degree of occipital hypometabolism correlated with disability and severity at baseline and follow-up, suggesting a potential role of FDG-PET in predicting outcomes in NMDAR-IgG AE.

10.1212/WNL.0000000000211737
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.